Novonesis (Novozymes) A/S (NSIS-B) — Financial Flexibility Index
Novonesis (Novozymes) A/S (NSIS-B) has a Financial Flexibility Index of 0.04x as of March 2026. Free cash flow of Dkr246.14 Million (operating CF Dkr167.06 Million minus capex Dkr79.08 Million) represents 0% of total liabilities (Dkr5.60 Billion). Check NSIS-B cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Novonesis (Novozymes) A/S Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Novonesis (Novozymes) A/S across 24 annual periods. For the full cash flow conversion analysis, see NSIS-B cash flow metrics.
Annual Financial Flexibility Index for Novonesis (Novozymes) A/S (2002–2025)
Year-by-year free cash flow to debt coverage for Novonesis (Novozymes) A/S. Explore Novonesis (Novozymes) A/S cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (DKK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | Dkr1.69 Billion | Dkr1.22 Billion | Dkr5.49 Billion | ▼ -10.3% |
| 2024 | 0.34x | Dkr1.38 Billion | Dkr1.02 Billion | Dkr4.02 Billion | ▼ -22.4% |
| 2023 | 0.44x | Dkr6.21 Billion | Dkr4.15 Billion | Dkr14.04 Billion | ▼ -11.8% |
| 2022 | 0.50x | Dkr6.90 Billion | Dkr4.01 Billion | Dkr13.76 Billion | ▲ +18.8% |
| 2021 | 0.42x | Dkr5.30 Billion | Dkr4.06 Billion | Dkr12.56 Billion | ▼ -26.1% |
| 2020 | 0.57x | Dkr5.29 Billion | Dkr4.36 Billion | Dkr9.27 Billion | ▲ +26.1% |
| 2019 | 0.45x | Dkr4.06 Billion | Dkr3.20 Billion | Dkr8.96 Billion | ▼ -25.3% |
| 2018 | 0.61x | Dkr5.01 Billion | Dkr3.68 Billion | Dkr8.26 Billion | ▼ -23.8% |
| 2017 | 0.80x | Dkr5.66 Billion | Dkr4.06 Billion | Dkr7.11 Billion | ▲ +11.9% |
| 2016 | 0.71x | Dkr4.92 Billion | Dkr3.84 Billion | Dkr6.91 Billion | ▲ +2.3% |
| 2015 | 0.69x | Dkr4.31 Billion | Dkr3.34 Billion | Dkr6.20 Billion | ▼ -5.0% |
| 2014 | 0.73x | Dkr5.23 Billion | Dkr4.53 Billion | Dkr7.15 Billion | ▲ +18.4% |
| 2013 | 0.62x | Dkr3.36 Billion | Dkr2.60 Billion | Dkr5.44 Billion | ▼ -13.0% |
| 2012 | 0.71x | Dkr3.94 Billion | Dkr2.76 Billion | Dkr5.54 Billion | ▼ -11.6% |
| 2011 | 0.80x | Dkr4.03 Billion | Dkr2.71 Billion | Dkr5.02 Billion | ▲ +4.7% |
| 2010 | 0.77x | Dkr3.65 Billion | Dkr2.32 Billion | Dkr4.76 Billion | ▲ +36.4% |
| 2009 | 0.56x | Dkr2.84 Billion | Dkr1.82 Billion | Dkr5.04 Billion | ▲ +15.5% |
| 2008 | 0.49x | Dkr2.66 Billion | Dkr1.70 Billion | Dkr5.45 Billion | ▲ +3.2% |
| 2007 | 0.47x | Dkr2.46 Billion | Dkr1.71 Billion | Dkr5.20 Billion | ▲ +5.9% |
| 2006 | 0.45x | Dkr2.04 Billion | Dkr1.53 Billion | Dkr4.57 Billion | ▼ -7.4% |
| 2005 | 0.48x | Dkr1.69 Billion | Dkr1.33 Billion | Dkr3.52 Billion | ▼ -3.8% |
| 2004 | 0.50x | Dkr1.62 Billion | Dkr1.29 Billion | Dkr3.24 Billion | ▼ -2.4% |
| 2003 | 0.51x | Dkr1.77 Billion | Dkr1.37 Billion | Dkr3.46 Billion | ▲ +35.8% |
| 2002 | 0.38x | Dkr1.55 Billion | Dkr1.18 Billion | Dkr4.10 Billion | — |